Livforsakringsbolaget Skandia Omsesidigt Has $8.42 Million Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Livforsakringsbolaget Skandia Omsesidigt increased its holdings in HCA Healthcare by 27.9%, owning 21,999 shares worth approximately $8.42 million after acquiring an additional 4,800 shares in Q2.
• HCA Healthcare's quarterly earnings report revealed an EPS of $6.84, surpassing estimates, with revenues of $18.61 billion, a year-over-year increase of 6.4%.
• The company recently declared a quarterly dividend of $0.72 per share, with a dividend yield of 0.7%, scheduled for payment on September 30th.

Livforsakringsbolaget Skandia Omsesidigt raised its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 27.9% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 21,999 shares of the company's stock after acquiring an additional 4,800 shares during the period. Livforsakringsbolaget Skandia Omsesidigt's holdings in HCA Healthcare were worth $8,419,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD lifted its stake in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. increased its holdings in HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock valued at $615,583,000 after acquiring an additional 587,036 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock worth $5,887,850,000 after buying an additional 1,699,713 shares in the last quarter. Nuveen LLC purchased a new stake in shares of HCA Healthcare during the first quarter worth about $569,217,000. Finally, Pacer Advisors Inc. grew its holdings in HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock valued at $466,815,000 after purchasing an additional 1,329,618 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by insiders.

HCA Healthcare Stock Performance

HCA traded up $5.51 during trading hours on Monday, reaching $407.81. The company's stock had a trading volume of 1,010,586 shares, compared to its average volume of 1,537,384. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $420.98. The company's 50-day moving average is $385.21 and its 200-day moving average is $366.40. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The firm has a market cap of $95.42 billion, a PE ratio of 17.14, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the prior year, the business earned $5.50 EPS. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

Analyst Ratings Changes

Several research firms recently issued reports on HCA. Wells Fargo & Company cut their price target on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a report on Thursday, August 14th. Royal Bank Of Canada reduced their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research report on Monday, July 28th. Truist Financial increased their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Finally, Robert W. Baird lifted their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $407.75.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.